In RA after first-line TNFi, improvements in disease activity & PROs were seen with 2nd line ETN and JAKi. Some measures had greater improvement in JAKi group. Some patients can benefit from TNF cycling. Pappas D CorEvitas Abs1588 https://t.co/cHW5tm97kx #ACR22 @RheumNow https://t.co/bx0p04AQzd
Links:
Outcomes of Etanercept and Janus Kinase Inhibitor Treatment After First-line Us…
http://bit.ly/3hChW5h
13-11-2022


